9 reports of this reaction
2.1% of all POTASSIUM NITRATE reports
#9 most reported adverse reaction
HYPERSENSITIVITY is the #9 most commonly reported adverse reaction for POTASSIUM NITRATE. There are 9 FDA adverse event reports linking POTASSIUM NITRATE to HYPERSENSITIVITY. This represents approximately 2.1% of all 437 adverse event reports for this drug.
Patients taking POTASSIUM NITRATE who experience hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPERSENSITIVITY is a less commonly reported adverse event for POTASSIUM NITRATE, but still significant enough to appear in the safety profile.
In addition to hypersensitivity, the following adverse reactions have been reported for POTASSIUM NITRATE:
The following drugs have also been linked to hypersensitivity in FDA adverse event reports:
HYPERSENSITIVITY has been reported as an adverse event in 9 FDA reports for POTASSIUM NITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPERSENSITIVITY accounts for approximately 2.1% of all adverse event reports for POTASSIUM NITRATE, making it a notable side effect.
If you experience hypersensitivity while taking POTASSIUM NITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.